Revvity to Present at Goldman Sachs Global Healthcare Conference

Rhea-AI Summary

Revvity (NYSE: RVTY) will present at the 45th Annual Goldman Sachs Global Healthcare Conference on June 10, 2024, at 8:00 a.m. ET in Miami, FL. The event will feature Prahlad Singh, the president and CEO of Revvity, who will provide an update on the company's strategic priorities. A live audio webcast and a replay of the presentation will be available on the company's website.

Positive

• Revvity is participating in a high-profile industry event, enhancing visibility.
• CEO Prahlad Singh's involvement may signify important updates or strategic shifts.
• Availability of a live webcast and replay increases accessibility for investors.

Negative

• The press release lacks specific strategic or financial data, creating uncertainty.
• No new product or partnership announcements were made, limiting immediate market impact.
• Potential for negative investor reaction if the updates provided are not well-received.

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY) will present at the 45^th Annual Goldman Sachs Global Healthcare Conference on Monday, June 10, 2024 at 8:00 a.m. ET in Miami, FL.

Prahlad Singh, president and chief executive officer, will provide an update on the Company and its strategic priorities. To register, click here.

A live audio webcast will be available on the Events section of the Company’s website at www.revvity.com. A replay of the presentation will be posted on the Revvity Investor Relations website after the event and will be available for at least 30 days.

About Revvity

At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2023 revenue of more than $2.7 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240528846410/en/

Investor Relations:

Steve Willoughby

steve.willoughby@revvity.com



Media Relations:

Chet Murray

(781) 663-5719

chet.murray@revvity.com

Source: Revvity

FAQ

When will Revvity present at the Goldman Sachs Global Healthcare Conference?

Revvity will present on June 10, 2024, at 8:00 a.m. ET.

Where is the Goldman Sachs Global Healthcare Conference taking place?

The conference is being held in Miami, FL.

Who will be presenting on behalf of Revvity at the conference?

Prahlad Singh, the president and CEO of Revvity, will be presenting.

Will there be a webcast of Revvity's presentation?

Yes, a live audio webcast and a replay will be available on Revvity's website.

What is the stock symbol for Revvity?

The stock symbol for Revvity is RVTY.